期刊文献+

一例Fechtner综合征临床与分子缺陷研究——附文献复习 被引量:8

Clinical and molecular study on Fechtner syndrome ——case report and literature review
原文传递
导出
摘要 目的对1例Fechtner综合征先证者及其家系进行临床与实验室研究并检测非肌性肌球蛋白重链9基因(MYH9)突变。方法采用瑞特染色观察先证者及其家系患者的外周血涂片血小板和中性粒细胞的特殊形态;透射电镜观察先证者血小板及中性粒细胞的超微结构。从先证者及其家系成员外周血白细胞中提取基因组DNA,PCR扩增MYH9的40个外显子及侧翼内含子序列,检测其基因突变。结果该家系中Fechtner综合征患者表现为血小板减少、巨大血小板、中性粒细胞包涵体,伴或不伴遗传性肾炎。先证者及其家系患病成员的MYH9改变为外显子40第5981位核苷酸C-T杂合改变,使第1933位密码子CGA(编码Arg)突变为终止密码TGA。结论国内首次报道Fechtner综合征家系。MYH9(外显子40)R1933X杂合改变是导致Fechtner综合征的原因。 Objective To identify clinical and laboratory abnormalities and genetic defect of Fechtnet syndrome in a Chinese family. Methods The characteristic morphological features of platelets and leukocytes were examined on blood smears with Wright' s-Giemsa staining and uhrastructure of platelet and leukocyte were investigated under electron microscope. Genomic DNA was isolated from peripheral blood of the proband and 9 members of his family. All the exons and exon-intron boundaries of the MYH9 gene were amplified by PCR followed by direct sequencing. Results Patients presented the characteristic clinical features including macrothrombocytopenia,leukocyte inclusions and/or hereditary nephritis. A heterozygous C to T mutation was found in the proband and three members of his family at nucleotide 5981 in exon 40 of MYH9 gene, resulting in a nonsense mutation which encoded truncated protein due to premature termination at the Arg 1933 eodon. Conclusion It is the first report of a Chinese family with Fechtner syndrome. The Arg(CGA) 1933→stop(TGA) nonsense mutation in MYH9 gene is a causative genetic defect.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2007年第3期160-164,共5页 Chinese Journal of Hematology
基金 国家自然科学基金资助项目(39870343) 江苏省重点学科135开放课题资助项目(135XY0602)
关键词 Fechtner综合征 血小板 基因 基因突变 Fechtner syndrome Platelet Gene Gene mutation
  • 相关文献

参考文献20

  • 1Peterson LC, Rao KV, Crosson JT, et al. Fechtner syndrome-a variant of Alport' s syndrome with leukocyte inclusions and macrothrombocytopenia. Blood, 1985, 65:397-406.
  • 2Toren A, Rozenfeld-Granot G, Rocca B,et al. Autosomal-dominant giant platelet syndromes: a hint of the same genetic defect as in Fechtner syndrome owing to a similar genetic linkage to chromosome 22q11-13. Blood, 2000, 96:3447-3451.
  • 3Seri M, Cusano R, Gangarossa S, et al. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes.The May-Hegglin/Fechtner Syndrome Consortium. Nat Genet, 2000,26 : 103-105.
  • 4Seri M, Savino M, Bordo D, et al. The Epstein syndrome: a further renal disorder due to mutations in the non-muscle myosin heavy chain 9 gene. Hum Genet, 2002,110 : 182-186.
  • 5张广森,易彦,徐敏,凌柱三.一个May-Hegglin异常家系非肌性肌球蛋白重链9基因突变位点的鉴定[J].中华医学杂志,2002,82(13):918-920. 被引量:17
  • 6邵秀茹,李家增,马军,展昭民,梁红,佘袭楠,鲁海玲,王来慈,贾垂明,吴丽洁,靳明华,陈立君.一例May-Hegglin异常家系临床及分子生物学研究[J].中华血液学杂志,2004,25(9):548-551. 被引量:17
  • 7Greinacher A, Mueller-Eckhardt C. Hereditary types of thrombocytopenia with giant platelets and inclusion bodies in the leukocytes.Blut, 1990,60:53-60.
  • 8Epstein CJ, Sahud MA, Piel CF, et al, Hereditary macrothrombocytopathia, nephritis and deafness. Am J Med, 1972,52:299-310.
  • 9Yoshinari M, Kunishima S, Miyabayashi S, et al. A unique immunofluorescence method promotes accurate diagnosis in MYH9 disorders:a case report. J Pediatr Hematol Oncol, 2004,26:579-583.
  • 10Heath KE, Campos-Barros A, Toren A. Nonmuscle myosin heavy chain A mutation define a spectrum of autosomal dominant macrothrombocytopenias:May-Hegglin anomaly and Fechtner, Sebastian,Epstein, and Alport-like syndromes. Am J Hum Genet, 2001, 69 :1033-1045.

二级参考文献8

共引文献24

同被引文献79

  • 1邵秀茹,李家增,马军,展昭民,梁红,佘袭楠,鲁海玲,王来慈,贾垂明,吴丽洁,靳明华,陈立君.一例May-Hegglin异常家系临床及分子生物学研究[J].中华血液学杂志,2004,25(9):548-551. 被引量:17
  • 2杨海燕,王兆钺.MYH9综合征的免疫荧光检测与基因分析[J].苏州大学学报(医学版),2006,26(6):973-976. 被引量:9
  • 3Moxey-Mims MM, Young G, Silverman A, et al. End stage renal disease in two pediatric patients with Fechtner syndrome. Pediatr Nephrol, 1999,13:782-786.
  • 4Arrondel C, Vodovar N, Knebelmann B, et al. Expression of the nonmuscle myosin heavy chain ⅡA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes . J Am Soc Nephrol, 2002,13:65-74.
  • 5Dong F, Li S, Pujol-Moix N, et al. Genotype-phenotype correlation in MYHg-related thrombocytopenia. Br J Haematol, 2005,130:620-627.
  • 6Kunishima S, Matsushita T, Kojima T, et al. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions. J Hum Genet, 2001,46:722-729.
  • 7Ghiggefi GM, Caridi G, Magrini U, et al. Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome). Am J Kidney Dis, 2003,41:95-104.
  • 8Huber TB, Kottgen M, Schilling B, et al. Interaction with podocin facilitates nephrin sigaling. J Biochemistry, 2001,276:41543-41546.
  • 9Kawachi H, Koike H, Kurihara H, et al. Cloing of rat homologre of podocin: expression in proteinuria states and in developing glomeruli. J Am Soc Nephrol, 2003,14,46-56.
  • 10Kaplan JM, Kim SH, North KN, et al. Mutation in ACTN4 encoding α-actinin-4,cause familial focal segmental glomerulosclerosis. Nature Genet, 2000,24:251-256.

引证文献8

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部